Symbol="GLMD"
AssetType="Common Stock"
Name="Galmed Pharmaceuticals Ltd"
Description="Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapies for the treatment of liver diseases. The company is headquartered in Tel Aviv, Israel."
CIK="1595353"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="16 ZE'EV TYOMKIN ST. (4TH FL.), TEL AVIV, IL"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1895600"
EBITDA="-13527000"
PERatio="None"
PEGRatio="0"
BookValue="7.14"
DividendPerShare="0"
DividendYield="0"
EPS="-8.2"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.377"
ReturnOnEquityTTM="-0.746"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-8.2"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="4"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.48"
EVToRevenue="-"
EVToEBITDA="0.51"
Beta="0.915"
num_52WeekHigh="14.18"
num_52WeekLow="0.8"
num_50DayMovingAverage="2.685"
num_200DayMovingAverage="1.209"
SharesOutstanding="2060200"
DividendDate="None"
ExDividendDate="None"
symbol="GLMD"
open="0.89"
high="0.93"
low="0.80"
price="0.84"
volume="114437.00"
latest_trading_day="2023-08-10"
previous_close="0.91"
change="-0.07"
change_percent="-7.1735%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="98"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="2"
Volume_recent_avg="315008"
Change_recent_avg="-0.05"
Delta_recent_avg="0.26"
Variance_recent_avg="0.13"
Change_ratio_recent_avg="-3.13"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="2"
Aroon_momentum_negative="98"
image_negative_thumbnail_id_1="1142"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0175.jpeg"
image_negative_thumbnail_id_2="172"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0004.jpeg"
image_neutral_thumbnail_id_1="521"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0078.jpeg"
image_neutral_thumbnail_id_2="539"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0060.jpeg"
image_positive_thumbnail_id_1="698"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0010.jpeg"
image_positive_thumbnail_id_2="1166"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Negative_0187.jpeg"
image_professor_thumbnail_id_1="1194"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
image_professor_thumbnail_id_2="1185"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
